Dr. Reddy's Laboratories Limited
RDY
$15.80
-$0.37-2.29%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 10.05% | 11.65% | -10.19% | 6.02% | -4.98% |
| Total Depreciation and Amortization | -5.83% | 17.73% | 3.90% | 2.14% | -1.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 134.74% | -547.98% | -85.42% | 255.51% | -159.26% |
| Change in Net Operating Assets | 105.91% | -22.91% | 41.01% | -373.61% | 76.65% |
| Cash from Operations | 224.25% | -29.53% | 9.20% | -26.59% | 143.78% |
| Capital Expenditure | -3.91% | 5.31% | -46.87% | 3.00% | -37.04% |
| Sale of Property, Plant, and Equipment | -108.79% | -47.83% | 5.07% | 275.61% | -89.86% |
| Cash Acquisitions | -- | 100.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -338.30% | -95.94% | 357.74% | -147.90% | 52.02% |
| Cash from Investing | -137.80% | 71.62% | 6.20% | -77.58% | 29.68% |
| Total Debt Issued | -367.82% | -89.25% | 60.80% | 2,717.60% | -92.67% |
| Total Debt Repaid | 17.32% | 29.66% | -45.00% | -12.78% | -138.16% |
| Issuance of Common Stock | -56.00% | -81.88% | 626.32% | -38.71% | 244.44% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | 100.00% | -- | -- | -- |
| Other Financing Activities | 11.51% | -115.62% | 922.45% | -10.55% | -24.17% |
| Cash from Financing | -1,319.01% | -96.38% | 68.57% | 1,881.89% | -110.12% |
| Foreign Exchange rate Adjustments | 4,686.15% | 78.44% | -234.74% | 126.03% | -140.47% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.80% | -72.81% | 389.24% | -410.28% | 92.85% |